NASDAQ · Biotechnology

Caris Life Sciences, Inc. (CAI) Stock

$29.13 +5.93% NASDAQ: CAI Healthcare

Valuation

MetricValue
Price$29.13
Market Cap$8.23B
P/E Ratio81.72
P/B Ratio14.53
P/S Ratio8.68
EPS (TTM)$-1.90
52-Week High$33.66
52-Week Low$14.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE18.77%
ROA8.55%
ROCE14.76%
Gross Margin68.72%
Operating Margin15.91%
Net Margin10.62%
Debt/Equity0.76
Current Ratio7.86

Annual Financials (USD)

Metric20202022202320242025
Revenue$294.0M$258.0M$306.0M$412.0M$812.0M
Operating Profit$139.0M$-316.0M$-320.0M$-257.0M$45.0M
Net Profit$28.0M$-321.0M$-341.0M$-282.0M$-538.0M
EPS$1.55$-1.57$-1.82$-2.70$-1.86
Op Margin47.3%-122.2%-104.4%-62.4%5.6%

Balance Sheet (USD)

Metric20202022202320242025
Total Assets$2.6B$717.0M$413.0M$344.0M$1.1B
Total Liabilities$1.9B$2.4B$2.6B$2.8B$548.0M
Cash$54.0M$107.0M$56.0M$64.0M$798.0M
Borrowings$1.7B$271.0M$217.0M$424.0M$379.0M

Latest News

Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing PR Newswire · Jul 14, 2026 BofA Adjusts Price Target on Caris Life Sciences to $23 From $28 MT Newswires · Jul 13, 2026 Caris Life Sciences (CAI) Launches Caris Detect Multi-Cancer Screening Test Insider Monkey · Jul 10, 2026 Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test PR Newswire · Jul 1, 2026 Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion? Insider Monkey · Jun 30, 2026

Cash Flow (USD)

Metric20202022202320242025
Operating Cash Flow$277.0M$-286.0M$-276.0M$-245.0M$83.0M
Investing Cash Flow$-253.0M$-325.0M$192.0M$44.0M$-33.0M
Financing Cash Flow$-240.0M$11.0M$0$0$-19.0M
Net Cash Flow$-7.0M$-558.0M$-51.0M$8.0M$732.0M
Free Cash Flow$58.0M$-328.0M$-298.0M$-254.0M$67.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.30
EV / EBITDA48.37
FCF Yield1.71%
Quick Ratio4.88
Interest Coverage3.27
Return 1Y-4.37%
Return 3Y—
Return 5Y—

Ownership

Insiders Held48.51%
Institutions Held56.74%
Institutions Float Held110.18%
Institutional HolderSharesReport Date
FMR, LLC30,785,5852026-03-31
J. H. Whitney Equity Partners VI, LLC18,256,6152026-03-31
Sixth Street Partners Management Company, L.P.14,385,3992026-03-31
Coatue Management LLC9,819,9922026-03-31
Braidwell LP 8,009,4472026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $334.56 -1.72% 38.93 $4.91T 0.32%
MSFTMicrosoft Corporation $534.92 +2.36% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $353.93 +1.62% 16.94 $4.28T 0.26%
AMZNAmazon.com, Inc. $261.33 +2.86% 19.82 $2.81T 0.00%
METAMeta Platforms, Inc. $724.50 +0.50% 27.93 $1.85T 0.28%

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc. (CAI) stock trades at $29.13 with a market capitalization of $8.23B. The stock is valued at a price-to-earnings (P/E) ratio of 81.72, price-to-book of 14.53, price-to-sales of 8.68. Over the past 52 weeks the stock has ranged between $14.19 and $33.66, and currently trades 13.4% below its 52-week high.

On profitability, Caris Life Sciences, Inc. generates a return on equity (ROE) of 18.77%, above the typical market average, return on capital employed of 14.76%, an operating margin of 15.91%, a net profit margin of 10.62%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1178.88 +0.79% JNJ Johnson & Johnson $260.66 +1.63% ABBV AbbVie Inc. $277.31 +1.80% MRK Merck & Company, Inc. Common Stock (new) $145.34 +2.08% UNH UnitedHealth Group Incorporated Common Stock (DE) $376.88 +1.60% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $659.76 +1.19% AMGN Amgen Inc. $413.31 +1.44% GILD Gilead Sciences, Inc. $151.18 +2.77% ABT Abbott Laboratories $99.69 +1.21% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides